Scientists identified two proteins as biomarkers of CTEPH severity and progression, a discovery that could pave the way for ...

Merck plans a Phase 3 trial of Winrevair after a Phase 2 study testing it in CpcPH due to HFpEF hit its main goal.

A routine surgery ended up causing life-threatening complications and a health crisis for columnist Mike Naple, who is glad ...

Low oxygen levels, or hypoxia, in early life impaired lung blood vessel growth, leading to severe pulmonary hypertension in a ...

Being a PH advocate is meaningful work, says columnist Jolie Lizana, who understands how much an encouraging word means to ...

Calcimedica's CM5480 was shown to improve blood flow and heart health measurements in a rat model of PAH, a new study reports ...

Cereno Scientific is seeking FDA clearance to launch a global clinical trial testing its CS1 therapy for pulmonary arterial ...

Merck Canada said it has successfully completed negotiations on its PAH therapy Winrevair with the pan‑Canadian Pharmaceutical Alliance.

Columnist Anna Jeter writes that, despite any setbacks, people with pulmonary hypertension should continue to take charge of their care.

Researchers have identified distinct genetic changes tied to the severity of idiopathic pulmonary arterial hypertension (IPAH) and chronic thromboembolic pulmonary hypertension (CTEPH). Data showed ...